北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第二临床医学院  > 心血管内科  > 期刊论文
学科主题: 临床医学
题名:
Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)
作者: Zhao, Shuiping1; Wang, Yongjun2; Mu, Yiming3; Yu, Bilian1; Ye, Ping4; Yan, Xiaowei5,6; Li, Zhanquan7; Wei, Yidong8; Ambegaonakr, Baishaili M.9; Hu, Dayi10; DYSIS-China Study Investigators
关键词: Cardiovascular diseases ; Dyslipidaemia ; Statin ; Lipid-lowering agents ; LDL cholesterol ; Non-HDL cholesterol
刊名: ATHEROSCLEROSIS
发表日期: 2014-08-01
DOI: 10.1016/j.atherosclerosis.2014.05.916
卷: 235, 期:2, 页:463-469
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Peripheral Vascular Disease
研究领域[WOS]: Cardiovascular System & Cardiology
关键词[WOS]: CORONARY-HEART-DISEASE ; HIGH-DENSITY LIPOPROTEIN ; CLINICAL-PRACTICE ; CHOLESTEROL GOAL ; DIABETES-MELLITUS ; HIGH-RISK ; STATIN ; MANAGEMENT ; ABNORMALITIES ; CANADA
英文摘要:

Background: Despite clear guideline recommendations, there is a paucity of data regarding the prevalence and type of persistent lipid profile abnormalities in patients on stable lipid-lowering therapy in China.

Methods: This cross-sectional trial included 25,697 patients treated with lipid-lowering agents from 122 centres between April 2012 and October 2012; all underwent clinical examination and had their latest fasting lipid profiles while on lipid-lowering therapy recorded. Logistic regression was performed to assess predictors for lipid abnormalities classified according to current Chinese guidelines.

Findings: Overall, 29.1% of patients had no lipid abnormalities, and 38.5% of patients did not achieve the therapeutic goal for low-density lipoprotein cholesterol (LDL-C), either as a single lipid anomaly or associated with low high-density lipoprotein cholesterol (HDL-C), elevated triglycerides, or both. Subjects with low risk were more likely than those with very high and high risk to be at target LDL-C levels. Furthermore, 10.4% of very high-risk patients and 11.1% of high-risk patients who attained the LDL-C goal failed to attain non-HDL-C goals. Diabetes was shown to be a strong predictor of failure in attaining non-HDL-C and both goals (OR 3.03; 3.22, 95% CI 2.58-3.55; 2.73-3.79, respectively).

Conclusion: Although great improvements have been made over the past decade, the large majority of very high-risk and high-risk patients treated with lipid-lowing agents still had one or more manifestations of dyslipidaemia. Further clinical evidence is needed to clarify whether adding other lipid-lowering agents to a statin will be associated with additional cardiovascular risk reduction. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

语种: 英语
所属项目编号: 39298
项目资助者: Merck &amp ; Co., Ltd (IISP)
WOS记录号: WOS:000342411000932
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/53602
Appears in Collections:北京大学第二临床医学院_心血管内科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Merck & Co Inc, Whitehouse Stn, NJ USA
2.Cent S Univ, Xiangya Hosp 2, Dept Cardiol, Changsha 410011, Hunan, Peoples R China
3.Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China
4.Chinese Peoples Liberat Army Gen Hosp, Dept Endocrinol, Beijing 100853, Peoples R China
5.Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China
6.Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing 100730, Peoples R China
7.Peking Union Med Coll, Beijing 100730, Peoples R China
8.Peoples Hosp Liaoning Prov, Dept Cardiol, Shenyang 110016, Peoples R China
9.Tonidi Univ, Peoples Hosp 10, Dept Cardiol, Shanghai 200072, Peoples R China
10.Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100044, Peoples R China

Recommended Citation:
Zhao, Shuiping,Wang, Yongjun,Mu, Yiming,et al. Prevalence of dyslipidaemia in patients treated with lipid-lowering agents in China: Results of the DYSlipidemia International Study (DYSIS)[J]. ATHEROSCLEROSIS,2014,235(2):463-469.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Zhao, Shuiping]'s Articles
[Wang, Yongjun]'s Articles
[Mu, Yiming]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Zhao, Shuiping]‘s Articles
[Wang, Yongjun]‘s Articles
[Mu, Yiming]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace